Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer
出版年份 2013 全文链接
标题
Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer
作者
关键词
Adenosine, A2A adenosine receptor, Cyclic AMP, Hypoxia, Inflammation, Tumor, Cancer immunotherapy, Adoptive immunotherapy, Tumor microenvironment, Immunosuppression, T lymphocytes, Regulatory T cells, Cytokines, Cytotoxicity
出版物
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 91, Issue 2, Pages 147-155
出版商
Springer Nature
发表日期
2013-01-19
DOI
10.1007/s00109-013-1001-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Host A2B Adenosine Receptors Promote Carcinoma Growth
- (2015) Sergey Ryzhov et al. NEOPLASIA
- CD73-Deficient Mice Are Resistant to Carcinogenesis
- (2012) J. Stagg et al. CANCER RESEARCH
- Cellular Constituents of Immune Escape within the Tumor Microenvironment
- (2012) S. P. Kerkar et al. CANCER RESEARCH
- Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury
- (2012) Li Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Sorting Through Subsets
- (2012) Christopher A. Klebanoff et al. JOURNAL OF IMMUNOTHERAPY
- Monoclonal TCR-redirected tumor cell killing
- (2012) Nathaniel Liddy et al. NATURE MEDICINE
- Adora2b Adenosine Receptor Engagement Enhances Regulatory T Cell Abundance during Endotoxin-Induced Pulmonary Inflammation
- (2012) Heidi Ehrentraut et al. PLoS One
- CD73: a potent suppressor of antitumor immune responses
- (2012) Paul. A. Beavis et al. TRENDS IN IMMUNOLOGY
- The development and immunosuppressive functions of CD4+ CD25+ FoxP3+ regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway
- (2012) Akio Ohta et al. Frontiers in Immunology
- Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's disease
- (2011) Anil Kachroo et al. ANNALS OF NEUROLOGY
- Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor
- (2011) Adam T. Waickman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
- (2011) J. Stagg et al. CANCER RESEARCH
- Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
- (2011) Sergio A. Quezada et al. IMMUNOLOGICAL REVIEWS
- Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
- (2011) Tangying Lu et al. JOURNAL OF CLINICAL INVESTIGATION
- Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors
- (2011) C. Cekic et al. JOURNAL OF IMMUNOLOGY
- Hypoxia-Inducible Factor-1α–Dependent Protection from Intestinal Ischemia/Reperfusion Injury Involves Ecto-5′-Nucleotidase (CD73) and the A2B Adenosine Receptor
- (2011) Melanie L. Hart et al. JOURNAL OF IMMUNOLOGY
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors--An Update
- (2011) B. B. Fredholm et al. PHARMACOLOGICAL REVIEWS
- Cancer cell killing via ROS: To increase or decrease, that is the question
- (2010) Jie Wang et al. CANCER BIOLOGY & THERAPY
- CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
- (2010) D. Jin et al. CANCER RESEARCH
- CD73: A Novel Target for Cancer Immunotherapy
- (2010) B. Zhang CANCER RESEARCH
- Adenosine receptors as drug targets
- (2010) Bertil B. Fredholm EXPERIMENTAL CELL RESEARCH
- CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in Mice
- (2010) Xiaofeng Sun et al. GASTROENTEROLOGY
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
- (2010) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adjuvants for cancer vaccines
- (2010) Thomas W. Dubensky et al. SEMINARS IN IMMUNOLOGY
- Anti–CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy
- (2010) Margaret K. Callahan et al. SEMINARS IN ONCOLOGY
- Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine
- (2009) Jiang-Ning Yang et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- In vitroinduction of T cells that are resistant to A2adenosine receptor-mediated immunosuppression
- (2009) Akio Ohta et al. BRITISH JOURNAL OF PHARMACOLOGY
- The A2aR adenosine receptor controls cytokine production in iNKT cells
- (2009) Michael Nowak et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Novel investigational adenosine A2Areceptor antagonists for Parkinson's disease
- (2009) Annalisa Pinna EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Adenosine regulates CD8 T-cell priming by inhibition of membrane-proximal T-cell receptor signalling
- (2009) Carsten Linnemann et al. IMMUNOLOGY
- The Cooperative Induction of Hypoxia-Inducible Factor-1 and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis
- (2009) M. Z. Noman et al. JOURNAL OF IMMUNOLOGY
- A2A Adenosine Receptor May Allow Expansion of T Cells Lacking Effector Functions in Extracellular Adenosine-Rich Microenvironments
- (2009) A. Ohta et al. JOURNAL OF IMMUNOLOGY
- CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease
- (2009) D. J. Friedman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response
- (2009) Michail V. Sitkovsky TRENDS IN IMMUNOLOGY
- Damage control by hypoxia-inhibited AK
- (2008) M. V. Sitkovsky BLOOD
- HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak
- (2008) J. C. Morote-Garcia et al. BLOOD
- Adenosine receptors in regulation of dendritic cell differentiation and function
- (2008) S. V. Novitskiy et al. BLOOD
- Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells
- (2008) M Sitkovsky et al. BRITISH JOURNAL OF PHARMACOLOGY
- Concerted Potent Humoral Immune Responses to Autoantigens Are Associated with Tumor Destruction and Favorable Clinical Outcomes without Autoimmunity
- (2008) T. Sittler et al. CLINICAL CANCER RESEARCH
- Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia
- (2008) M. V. Sitkovsky et al. CLINICAL CANCER RESEARCH
- Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice
- (2008) A. Bai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started